Nonoccupational Exposure

Nonoccupational Exposure General Information

Here we intend to familiarize you with the most important information regarding Nonoccupational Exposure to HIV with which the average patient should be acquainted. One should be well aware of the difference between the occupational exposure to the HIV virus and the nonoccupational one. The most common nonoccupational ways in which a patient can become exposed to the dangerous virus that causes this severe clinical condition include sharing infected needles, unprotected sexual intercourse, and other similar circumstances. Patients who have undergone Nonoccupational Exposure to HIV have greater chances of reducing their risk of developing this severe medical condition than those who are continually and / or frequently exposed to the virus (patients who are constantly exposed to this pathogen in their occupation setting, for example).

Scientists have not yet been able to determine the exact risk of transmission of this severe clinical disorder with sharing infected needles and / or though sexual intercourse (2 of the most common ways of transmitting this condition from one patient to another). However, studies have been able to estimate the risks of developing HIV after certain types of exposures outside the individual’s occupational setting. For example, the risk involved by a single receptive anal intercourse is of 2%, while a receptive vaginal intercourse presents 0.1% risks of infecting the healthy individual, provided that the patient receives an appropriate prophylactic medical care.

Nonoccupational Exposure Symptoms

Unfortunately, we cannot provide you with a professional and / or accurate list of the common clinical manifestations that such a condition (Nonoccupational Exposure to the HIV virus) is able to trigger, as it is a well known fact that this infectious disorder tends to remain asymptomatic, at least in its early stages. This is what makes this condition challenging to detect, as the patient will not seek professional health care support unless he or she develops some unpleasant, disturbing clinical manifestations. Only in rare cases, patients who are unsure whether their partner was HIV-negative undergo the necessary medical tests that provide him or her with an accurate diagnosis.

However, in most cases, individuals who have undergone Nonoccupational Exposure to HIV ignore the danger in which they are and they do not seek the needed professional medical support. We will now familiarize you with the most common clinical manifestations that may arise in the acute stages of this medical condition. You may be surprised to find out that the initial symptoms of this infectious condition are known to resemble those of a common flu: diarrhea, rash, sore throat, joint pain, muscle pain, headache, fever, and so on. In time, the patient’s immune system becomes affected by this severe clinical illness; patients who develop HIV due to occupational and / or Nonoccupational Exposure to the virus will eventually present a weakened immune system. In other words, such individuals will become abnormally susceptible to developing severe infectious conditions. The presence of HIV will also trigger the presence of several, disturbing respiratory symptoms such as productive cough, dry cough, and so on. If you are interested in acquiring further professional information regarding this matter, we strongly advise you to seek professional medical attention as soon as possible.

Nonoccupational Exposure Treatment

Individuals should be well aware of the fact that the most efficient way in which one can prevent becoming infected with the dangerous virus that is responsible for the development of HIV (the immuno-deficiency virus) is to avoid either occupational or Nonoccupational Exposure to this pathogen. Studies have shown that the use of antiretroviral treatment trial is not able to replace the behaviors that are known to be very helpful in avoiding an unwanted exposure to this pathogen (especially sexual abstinence, proper use of condoms, abstinence from the use of injectable drugs, and so on). Although there is a treatment trial which can be prescribed after the patient has been subjected to Nonoccupational Exposure, it is known to lead to far less satisfactory results than in the case of patients who have avoided becoming exposed to the immuno-deficiency virus in the first place.

The treatment trial that is prescribed to a patient who has undergone an accidental exposure to this pathogen is part of the HIV prophylaxis (the prevention of this medical condition). The most common medication therapy that is prescribed in the case of patients who have been subjected to an unwanted exposure to the HIV virus consists in the administration of antiretroviral medical products (commonly abbreviated as ARVs), being one of the most effective PEP (post-exposure prophylaxis) options available so far. Hopefully, after the administration of this clinical remedy, the patient will not become infected with HIV, even if he or she has undergone a Nonoccupational Exposure. Most ARVs medical products can be purchased only with a special prescription from the patient’s doctor. The individual’s intake of such clinical remedies should begin as soon as the patient can; however, the individual is recommended to start the intake of the prescribed medication within 3 days after the exposure.A patient may also be prescribed a combination between 2 or 3 different ARVs. The treatment span of such an individual may last for up to a whole month, provided that the patient’s organism is able to tolerate the unwanted side effects of this medical remedy.

The use of PEP has been implemented as the standard clinical procedure for a patient who has undergone a severe form of Nonoccupational Exposure to the immuno-deficiency virus. The sooner the individual receives his or her first dose of this clinical remedy, the greater are his or her chances of avoiding becoming infected with this disorder (HIV). Studies have shown that the administration of the PEP prophylactic routine is able to reduce the individual’s risk of developing the severe immuno-deficiency syndrome by approximately 79%. However, before you are administered a remedy for your condition, you will have to talk to your personal health care provider and find out more about the risks and benefits that such a treatment trial has to offer you. Individuals who are suffering from a severe allergic reaction to the PEP prophylactic medicine may not be allowed to use it.